Skip to main content
. 2022 Mar 3;260(8):2437–2447. doi: 10.1007/s00417-022-05586-w

Table 2.

Distribution of HARBOR study eyes across baseline MNV lesion types

Baseline MNV lesion type, n (%) Monthly treated eyes
(n = 346)
PRN-treated eyes
(n = 354)
Pooled study eyes
(N = 700)
Type 1 123 (35.5) 140 (39.5) 263 (37.6)
Type 2/M 151 (43.6) 136 (38.4) 287 (41.0)
Any type 3 72 (20.8) 78 (22.0) 150 (21.4)

MNV macular neovascularization, PRN pro re nata (as-needed), type 2/M type 2/mixed type 1 and 2